Put Postpartum Hemorrhage Meds in Perspective
November 2024
Recent news about states reclassifying misoprostol as a controlled substance is putting focus on how to treat postpartum hemorrhage (PPH).
Misoprostol is now a C-IV med in Louisiana due to changes in abortion laws...and it’s too soon to say if other states will follow suit or how it will impact PPH treatment.
Around 5% of pregnant patients will have PPH...a total blood loss of at least 1,000 mL after delivery OR when blood loss leads to signs or symptoms of hypovolemia. This can happen up to 12 weeks postpartum.
Get concise advice on drug therapy, plus unlimited access to CE
Hospital Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote